Literature DB >> 19945916

An outbreak of neurological autoimmunity with polyradiculoneuropathy in workers exposed to aerosolised porcine neural tissue: a descriptive study.

Daniel H Lachance1, Vanda A Lennon, Sean J Pittock, Jennifer A Tracy, Karl N Krecke, Kimberly K Amrami, Eric M Poeschla, Robert Orenstein, Bernd W Scheithauer, James J Sejvar, Stacy Holzbauer, Aaron S Devries, P James B Dyck.   

Abstract

BACKGROUND: Between November, 2006, and May, 2008, a subacute neurological syndrome affected workers from two swine abattoirs in Minnesota and Indiana who had occupational exposure to aerosolised porcine brain. We aimed to describe the pathogenic and immunological characteristics of this illness.
METHODS: All patients from two abattoirs who presented or were referred to the Mayo Clinic (Rochester, MN, USA) with neurological symptoms were included. We recorded details of exposure to aerosolised brain tissue and did comprehensive neurological, laboratory, neuroimaging, electrophysiological, pathological, and autoimmune serological assessments. Healthy controls were recruited from the community and from workers at the plant in Minnesota.
FINDINGS: 24 patients were identified (21 from Minnesota, three from Indiana). The shortest duration from first exposure to symptom onset was 4 weeks. No infectious agent that could trigger disease was identified. All patients developed polyradiculoneuropathy, which was usually sensory predominant and painful. Two patients had initial CNS manifestations: transverse myelitis and meningoencephalitis. Nerve conduction studies localised abnormalities to the most proximal and distal nerve segments. Quantitative sensory and autonomic testing revealed involvement of large and small sensory fibres and sweat fibres. MRI showed prominent abnormalities of roots and ganglia. Nerve biopsies identified mild demyelination, axonal degeneration, and perivascular inflammation. Protein concentrations were high in the CSF of 18 (86%) of 21 patients. Sera from all patients and 29 (34%) of 85 unaffected workplace controls (but none of 178 community controls) had a distinctive neural-reactive IgG; 75% of patients' sera contained an IgG specific to myelin basic protein. Seropositivity correlated directly with exposure risk in patients and controls. 17 patients required immunomodulatory therapies, six improved spontaneously, and one was lost to follow-up after exposure stopped.
INTERPRETATION: The neurological disorder described is autoimmune in origin and is related to occupational exposure to multiple aerosolised porcine brain tissue antigens. The pattern of nerve involvement suggests vulnerability of nerve roots and terminals where the blood-nerve barrier is most permeable. FUNDING: Mayo Clinic Foundation; Minnesota Department of Health; Centers for Disease Control and Prevention. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19945916     DOI: 10.1016/S1474-4422(09)70296-0

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  18 in total

1.  Immunotherapy-responsive pain in an abattoir worker with fluctuating potassium channel-complex IgG.

Authors:  Jeffrey W Meeusen; Vanda A Lennon; Christopher J Klein
Journal:  Neurology       Date:  2012-10-10       Impact factor: 9.910

Review 2.  Animal models of peripheral neuropathy due to environmental toxicants.

Authors:  Deepa B Rao; Bernard S Jortner; Robert C Sills
Journal:  ILAR J       Date:  2014

Review 3.  Clinical spectrum and diagnostic value of antibodies against the potassium channel related protein complex.

Authors:  M T Montojo; M Petit-Pedrol; F Graus; J Dalmau
Journal:  Neurologia       Date:  2014-01-30       Impact factor: 3.109

4.  Potassium channel complex autoimmunity induced by inhaled brain tissue aerosol.

Authors:  Jeffrey W Meeusen; Christopher J Klein; Istvan Pirko; Keegan E Haselkorn; Thomas J Kryzer; Sean J Pittock; Daniel H Lachance; P James Dyck; Vanda A Lennon
Journal:  Ann Neurol       Date:  2012-03       Impact factor: 10.422

5.  Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1.

Authors:  Brandi N Reeves; Shaker R Dakhil; Jeff A Sloan; Sherry L Wolf; Kelli N Burger; Arif Kamal; Nguyet A Le-Lindqwister; Gamini S Soori; Anthony J Jaslowski; Joseph Kelaghan; Paul J Novotny; Daniel H Lachance; Charles L Loprinzi
Journal:  Cancer       Date:  2012-03-13       Impact factor: 6.860

6.  Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1.

Authors:  Charles L Loprinzi; Brandi N Reeves; Shaker R Dakhil; Jeff A Sloan; Sherry L Wolf; Kelli N Burger; Arif Kamal; Nguyet A Le-Lindqwister; Gamini S Soori; Anthony J Jaslowski; Paul J Novotny; Daniel H Lachance
Journal:  J Clin Oncol       Date:  2011-03-07       Impact factor: 44.544

7.  Epidemiologic investigation of immune-mediated polyradiculoneuropathy among abattoir workers exposed to porcine brain.

Authors:  Stacy M Holzbauer; Aaron S DeVries; James J Sejvar; Christine H Lees; Jennifer Adjemian; Jennifer H McQuiston; Carlota Medus; Catherine A Lexau; Julie R Harris; Sergio E Recuenco; Ermias D Belay; James F Howell; Bryan F Buss; Mady Hornig; John D Gibbins; Scott E Brueck; Kirk E Smith; Richard N Danila; W Ian Lipkin; Daniel H Lachance; P James B Dyck; Ruth Lynfield
Journal:  PLoS One       Date:  2010-03-19       Impact factor: 3.240

8.  Autoimmune neuromuscular disorders.

Authors:  Jessica Kraker; Saša A Zivković
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

9.  Emerging zoonoses: the "one health approach".

Authors:  Giulia Rabozzi; Luigi Bonizzi; Eleonora Crespi; Chiara Somaruga; Maryam Sokooti; Ramin Tabibi; Francesca Vellere; Gabri Brambilla; Claudio Colosio
Journal:  Saf Health Work       Date:  2012-03-08

Review 10.  Molecular Pathogenesis of Anti-NMDAR Encephalitis.

Authors:  Hao Ding; Zhihong Jian; Creed M Stary; Wei Yi; Xiaoxing Xiong
Journal:  Biomed Res Int       Date:  2015-06-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.